5,6,7,8-四氢萘-2-基乙胺 | 50878-03-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: 5,6,7,8-四氢萘-2-基乙胺
• 英文名称: N-(5,6,7,8-tetrahydronaphth-2-yl)acetamide
• 英文别名: 2-acetamido-5,6,7,8-tetrahydronaphthalene；N-tetralin-6-ylacetamide；N-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide；6-Acetylamino-tetralin
• CAS: 50878-03-0
• 化学式: C₁₂H₁₅NO
• mdl: MFCD00089685
• 分子量: 189.257
• InChiKey: QJEVQGGWBHGIBZ-UHFFFAOYSA-N

物化性质

• 熔点：
  106 °C
• 沸点：
  374.4±31.0 °C(Predicted)
• 密度：
  1.117±0.06 g/cm3(Predicted)
• 溶解度：
  >28.4 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xn
• 危险类别码：
  R22
• 海关编码：
  2924299090
• 危险性防范说明：
  P264,P270,P301+P312,P330,P501
• 危险性描述：
  H302
• 储存条件：
  存储条件：2-8°C，避光干燥。

SDS

Name:	N1-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide, 97% Material Safety Data Sheet
Synonym:	6-(Acetamido)tetralin
CAS:	50878-03-0

Section 1 - Chemical Product MSDS Name: N1-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide, 97% Material Safety Data Sheet
Synonym: 6-(Acetamido)tetralin

---

SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
50878-03-0	N1-(5,6,7,8-Tetrahydronaphthalen-2-yl)	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 22

---

SECTION 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW Harmful if swallowed. Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

SECTION 4 - FIRST AID MEASURES
Eyes:
Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

SECTION 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

SECTION 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

SECTION 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 50878-03-0: Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 101 - 103 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C12H15NO
Molecular Weight: 189

---

SECTION 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Acids, bases, oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

SECTION 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 50878-03-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N1-(5,6,7,8-Tetrahydronaphthalen-2-yl)acetamide - Not listed by ACGIH, IARC, or NTP.

---

SECTION 12 - ECOLOGICAL INFORMATION

---

SECTION 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations.

---

SECTION 14 - TRANSPORT INFORMATION IATA No information available. IMO No information available. RID/ADR No information available.

---

SECTION 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection) CAS# 50878-03-0: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 50878-03-0 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 50878-03-0 is not listed on the TSCA inventory. It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
MSDS Creation Date: 6/10/2003 Revision #0 Date: Original. The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5,6,7,8-四氢萘-2-基乙胺 在 盐酸 、 硫酸 、 硝酸 、 溶剂黄146 作用下， 生成 methyl-(3-nitro-5,6,7,8-tetrahydro-[2]naphthyl)-amine
  参考文献：
  名称：

  Schroeter, Justus Liebigs Annalen der Chemie, 1922, vol. 426, p. 132

  摘要：

  DOI：
• 作为产物：
  描述：

  7-硝基-3,4-二氢-2H-1-萘酮 在 5%-palladium/activated carbon 盐酸 、 氢气 作用下， 以 1,4-二氧六环 、 乙醇 、 水 、 乙酸乙酯 为溶剂， 20.0 ℃ 、413.7 kPa 条件下， 反应 32.0h， 生成 5,6,7,8-四氢萘-2-基乙胺
  参考文献：
  名称：

  WO2006/104406

  摘要：

  公开号：

文献信息

• An Electrochemical Beckmann Rearrangement: Traditional Reaction via Modern Radical Mechanism
  作者：Li Tang、Zhi‐Lv Wang、Yan‐Hong He、Zhi Guan

  DOI：10.1002/cssc.202001553

  日期：2020.9.18

  electrochemical Beckmann rearrangement, i. e. the direct electrolysis of ketoximes to amides, is presented for the first time. Using a constant current as the driving force, the reaction can be easily carried out under neutral conditions at room temperature. Based on a series of mechanistic studies, a novel radical Beckmann rearrangement mechanism is proposed. This electrochemical Beckmann rearrangement does

  摘要：很少研究电合成作为将杂原子引入碳骨架的潜在手段。在此，电化学贝克曼重排，即。e。首次介绍了酮肟的直接电解成酰胺。使用恒定电流作为驱动力，可以在室温下在中性条件下容易地进行反应。在一系列机理研究的基础上，提出了一种新颖的自由基贝克曼重排机理。这种电化学贝克曼重排不遵循经典贝克曼重排的反迁移规则。
• Tricyclic dihydropyridazinones and pharmaceutical compositions
  申请人：Boehringer Biochemia Robin, S.p.A.

  公开号：US04692447A1

  公开（公告）日：1987-09-08

  The tricyclic dihydropyridazinone derivatives having formula I ##STR1## are endowed with interesting hypotensive, vasodilating, antiaggregant, antithrombotic and cytoprotective properties and are therefore useful in human or veterinary medicine.

  具有以下化学式的三环二氢吡啶并嗪衍生物具有降压、扩血管、抗血小板聚集、抗血栓和细胞保护等有趣的性质，因此在人类或兽医学中具有用途。
• [EN] COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR<br/>[FR] COMPOSÉS ET PROCÉDÉS DE MODULATION D'IDO ET DE TDO, ET INDICATIONS POUR CEUX-CI
  申请人：PLEXXIKON INC

  公开号：WO2019183145A1

  公开（公告）日：2019-09-26

  Disclosed are compounds of Formula (I) and (Ia) or a pharmaceutically acceptable salt, a solvate, a tautomer, a stereoisomer or a deuterated analog thereof, wherein R4, R5, R6, and R7 are as described in any of the embodiments described in this disclosure; compositions thereof; and uses thereof.

  本公开了化合物的结构式（I）和（Ia），或其药用盐、溶剂合物、互变异构体、立体异构体或重氘化类似物，其中R4、R5、R6和R7如本公开所述的各实施例中所述；其组合物；以及其用途。
• Visible-Light-Induced Beckmann Rearrangement by Organic Photoredox Catalysis
  作者：Li Tang、Zhi-Lv Wang、Hai-Lan Wan、Yan-Hong He、Zhi Guan

  DOI：10.1021/acs.orglett.0c02168

  日期：2020.8.7

  A facile and general strategy for efficient direct conversion of oximes to amides using an inexpensive organic photocatalyst and visible light is described. This radical Beckmann rearrangement can be performed under mild conditions. Various alkyl aryl ketoximes and diaryl ketoximes can be effectively converted into the corresponding amides in excellent yields.

  描述了使用廉价的有机光催化剂和可见光将肟有效地直接转化为酰胺的简便且通用的策略。彻底的贝克曼重排可以在温和的条件下进行。各种烷基芳基酮肟和二芳基酮肟可以有效地转化为相应的酰胺，产率很高。
• Indoline compounds and to pharmaceutical compositions containing them
  申请人：——

  公开号：US20030199555A1

  公开（公告）日：2003-10-23

  A compound of formula (I): 1 wherein: R 1 and R 2 together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or trifluoromethyl, and R 3 represents hydrogen, or R 1 represents hydrogen, and R 2 and R 3 together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or trifluoromethyl, its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicaments.

  式（I）的化合物：其中：R1和R2一起形成一个苯环，该苯环可以选择性地被卤素或烷基、烷氧基、氰基、硝基、羟基、氨基、烷基氨基、二烷基氨基或三氟甲基取代，而R3代表氢，或者R1代表氢，而R2和R3一起形成一个苯环，该苯环可以选择性地被卤素或烷基、烷氧基、氰基、硝基、羟基、氨基、烷基氨基、二烷基氨基或三氟甲基取代，其对映体、非对映体异构体以及其与药学上可接受的酸或碱形成的加合物，以及药物。